178 related articles for article (PubMed ID: 16752515)
1. [Medical therapy in critical lower limb ischemia when immediate revascularization is not feasible].
Melillo E; Nuti M; Buttitta F; Balbarini A
G Ital Cardiol (Rome); 2006 May; 7(5):317-35. PubMed ID: 16752515
[TBL] [Abstract][Full Text] [Related]
2. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of non-reconstructable lower critical limb ischemia?
Melillo E; Nuti M; Pedrinelli R; Buttitta F; Balbarini A
Minerva Cardioangiol; 2006 Aug; 54(4):481-98. PubMed ID: 17016419
[TBL] [Abstract][Full Text] [Related]
3. Tolerance of Iloprost and results of treatment of chronic severe lower limb ischaemia in diabetic patients. A retrospective study of 64 consecutive cases.
Duthois S; Cailleux N; Benosman B; Lévesque H
Diabetes Metab; 2003 Feb; 29(1):36-43. PubMed ID: 12629446
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of patients with critical limb ischemia treated with iloprost: response rate and predictive criteria. A retrospective analysis of 102 patients.
Melillo E; Lucaccini E; Berchiolli R; Adami D; Nuti M; Dell'Omo G; Farina A; Panigada G; Roberts AT; Meini S
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5233-5241. PubMed ID: 28051243
[TBL] [Abstract][Full Text] [Related]
5. Is it possible to improve outcome in patients undergoing surgery for acute limb ischemia? Can iloprost, a prostacyclin analogue, be helpful?
de Donato G; Gussoni G; de Donato G
Chir Ital; 2004; 56(6):769-80. PubMed ID: 15771029
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of prostanoids in patients with critical leg ischemia].
Brodszky V; Farkas K; Járai Z; Landi A; Pécsvárady Z; Baji P; Balogh O; Gulácsi L; Péntek M
Orv Hetil; 2011 Dec; 152(51):2047-55. PubMed ID: 22130202
[TBL] [Abstract][Full Text] [Related]
7. Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.
Sen I; Agarwal S; Tharyan P; Forster R
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009366. PubMed ID: 29658630
[TBL] [Abstract][Full Text] [Related]
8. Prostanoids for critical limb ischaemia.
Ruffolo AJ; Romano M; Ciapponi A
Cochrane Database Syst Rev; 2010 Jan; (1):CD006544. PubMed ID: 20091595
[TBL] [Abstract][Full Text] [Related]
9. Prostanoids for Critical Limb Ischemia: A Clinical Review and Consideration of Current Guideline Recommendations.
Meini S; Dentali F; Melillo E; de Donato G; Mumoli N; Mazzone A
Angiology; 2020 Mar; 71(3):226-234. PubMed ID: 31769315
[TBL] [Abstract][Full Text] [Related]
10. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia.
Brass EP; Anthony R; Dormandy J; Hiatt WR; Jiao J; Nakanishi A; McNamara T; Nehler M;
J Vasc Surg; 2006 Apr; 43(4):752-9. PubMed ID: 16616232
[TBL] [Abstract][Full Text] [Related]
11. Transcutaneous oxygen and carbon dioxide levels with iloprost administration in diabetic critical limb ischemia.
Melillo E; Ferrari M; Balbarini A; Pedrinelli R
Vasc Endovascular Surg; 2006; 40(4):303-11. PubMed ID: 16959724
[TBL] [Abstract][Full Text] [Related]
12. Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study.
Altstaedt HO; Berzewski B; Breddin HK; Brockhaus W; Bruhn HD; Cachovan M; Diehm C; Dörrler J; Franke CS; Gruss JD
Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):573-8. PubMed ID: 7692455
[TBL] [Abstract][Full Text] [Related]
13. Transcutaneous gases determination in diabetic critical limb ischemia.
Melillo E; Ferrari M; Balbarini A; Pedrinelli R
Diabetes Care; 2005 Aug; 28(8):2081-2. PubMed ID: 16043766
[No Abstract] [Full Text] [Related]
14. The ILAILL study: iloprost as adjuvant to surgery for acute ischemia of lower limbs: a randomized, placebo-controlled, double-blind study by the italian society for vascular and endovascular surgery.
de Donato G; Gussoni G; de Donato G; Andreozzi GM; Bonizzoni E; Mazzone A; Odero A; Paroni G; Setacci C; Settembrini P; Veglia F; Martini R; Setacci F; Palombo D
Ann Surg; 2006 Aug; 244(2):185-93. PubMed ID: 16858180
[TBL] [Abstract][Full Text] [Related]
15. Iloprost in the management of peripheral arterial disease in patients with diabetes mellitus.
Piaggesi A; Vallini V; Iacopi E; Tedeschi A; Scatena A; Goretti C; Rizzo L
Minerva Cardioangiol; 2011 Feb; 59(1):101-8. PubMed ID: 21285935
[TBL] [Abstract][Full Text] [Related]
16. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W
Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
[TBL] [Abstract][Full Text] [Related]
17. Intra-Arterial Administration of Iloprost in Patients Undergoing Endovascular or Hybrid Revascularization Procedures for Peripheral Arterial Disease.
Benedetto F; La Corte F; Spinelli D; Derone G; Cutrupi A; Varrà A; Barillà C
Ann Vasc Surg; 2020 Oct; 68():426-433. PubMed ID: 32428644
[TBL] [Abstract][Full Text] [Related]
18. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
Duthois S; Cailleux N; Lévesque H
J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
[TBL] [Abstract][Full Text] [Related]
19. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
[No Abstract] [Full Text] [Related]
20. Effect of Iloprost infusion on metabolism in critical limb ischemia, utilizing microdialysis. A pilot study.
Danielsson P; Metzsch C; Norgren L
Int Angiol; 2004 Sep; 23(3):259-62. PubMed ID: 15765041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
